A snippet from the following interview: The Regeneration Generation: A Conversation With Bob Hariri, Vice-Chairman and Co-Founder of Human Longevity Inc.
The LavaAmp is a portable PCR thermocycler that has the potential to become the default garage biology (home biology, bioDIY, DIYbio) tool once it hits the market. Think of Apple II for personal computing or MakerBot for 3D printing. The 1st LavaAmp prototype was shipped this week from Biodesic to Gahaga Biosciences and the process… Continue reading LavaAmp: cheapest pocket PCR thermocycler dreamed for DIY biologists
Take a look at the FDA Application Approvals 2000-2008 visualization (created by user mktlgcs) over at IBM’s Many Eyes to get an aerial view on the US. pharmaceutical industry.
Friend Dan Erlanson (Co-Editor in Chief of the niche and smart Fragment-based Drug Design blog Practical Fragments) sent me this story on the recession proof business model of a biotech company called BioBlocks and his founder medical chemist Peter Pallai: Approximately one out of 5,000 compounds pass an initial screen, hit the designated biological target,… Continue reading BioBlocks: outsourcing biotech, one block at a time
In the past months Thomas Goetz begun writing a book on the radical changes already ongoing but mostly upcoming in healthcare due to affordable new technologies and quantitative approaches in personalized genomics and medicine. The book is to be called The Decision Tree (explanation below) accompanied by a new website. Thomas is the perfect man… Continue reading The Decision Tree: Thomas Goetz’s upcoming book on predictive/personalized medicine
forwarded, nonpersonal mail from Maya Kennard (you might get that email too): Resource link/Story suggestion for your website:Title: VADLO – Biomedical Search Engine Description: Vadlo is a search engine for the biology/biomedical scientists, educators, clinicians and reference librarians. References Also check the Daily cartoons! The idea is that we feed them with searches and links and… Continue reading Vadlo, the beta biomedical search engine wants to scale up!
What do you think, which company launched the first commercial and comprehensive personal genome service (based on a genome-wide SNP scan) on the market and exactly when? We have 2 candidates here in the ring deCODE Genetics (founded in 1996, Iceland) and 23andMe (founded in 2006, USA), the Amundsen and Scott of personal genomics. (please… Continue reading Who’s first? Happy First Birthday, commercial personal genomics!
The newest Nature issue concentrates on personal genomics and its consequences via many types of articles some of them with free access. I only read 1 piece so far by Erika Check Hayden, who has the exclusive freedom at Nature to always pick the best stories and write on any of them, but being a… Continue reading Nature Personal Genomics Very Special
This is a golden day for 23andMe despite all crisis worries: Mountain View, CA (PRWEB) October 30, 2008 — TIME Magazine announced today that the Personal Genome Service™ from 23andMe, Inc. has been named 2008’s Invention of the Year. 23andMe was chosen as the year’s most significant invention for its exceptional work in making personal… Continue reading Golden day for 23andMe: Time’s 2008 Invention of the Year
I ordered my first commercial genetic profile from 23andMe on the 9th of September online, FedExed my 2 ml saliva from Budapest to 23andMe, Mountain View on the 12th of September. I got the results today. That said within 3 weeks since the birth of the idea I purchased more than 500 000 SNPs of… Continue reading Mountain View – Budapest: 20 days to get my 23andMe profile!
The Institute for the Future‘s X2 project is all about tracing future trends in science and technology As the steward of the Biomedical Sciences and Biotechnology Group I collect signals in these fields on which some forecasts can be based later on. Here are some issues I found future sensitive enough recently: GlaxoSmithKline collaborates with… Continue reading Science X2 signals: big pharmas, stem cells, mobile MRI
It was already known that amongst the Google top people Sergey Brin is the one who is most interested in pushing biotechnology and the biomedical sciences: in his Stanford years he was interested in biology courses according to The Google Story, he married Anne Wojcicki (who graduted from biology at Yale), Google invested $4.4 million… Continue reading Sergey Brin, Gly2019Ser & a real chance against Parkinson disease/aging!
There is a nice initiative now in Budapest dedicated to the present and future of high technology: a new private university momentarily dubbed as Aquincum Institute of Technology (AIT) will be built near to the Graphisoft Park in Óbuda (Aquincum) concentrating on competitive information-/biotechnology (mainly bioinformatics) education and entrepreneurship. The main instigator of the project… Continue reading Aquincum Institute of Technology, Budapest, IT & BT shaking hands
As the second operation of building my genetically well informed future yesterday (2 days after completing the order) I collected 2 ml of my saliva with the help of 23andMe’s Oragene DNA self-collection kit manufactured by DNA Genotek. First operation has been the sequencing of the D-loop of my mitochondrial DNA out of 5 ml… Continue reading My personalized genetics: 2 ml saliva FedExed to 23andMe!
It was time for me to enter personally into the age of commercialized-personalized genetics/genomics and not just to talk about it! New price, new customers! Here is my suggestion to the sales department of 23andMe! 23andMe Democratizes Personal Genomics With New Analytical Platform
If “Science has a really serious marketing problem” as Larry Page observed, then life extension technologies face even bigger marketing problems. I am definitely not a marketing expert but realized the problem early on when thinking about the lag-phase period of a robust life extension technology. So I made a short email interview with Dave… Continue reading The marketing problem of life extension technologies
Last year I was probably the only SciFoo Camper with an explicit life extension commitment. I suggested & held a session which was related a bit to partial immortalization but was rather about the systems biology perspective in general, illustrated with some examples. So throughout the terrific SciFoo Camp 2007 life extension as a conversation… Continue reading Life extension people & session at SciFoo 2008, Googleplex!
The concept of decellularizing complex organs in cadavers and reseeding the remaining matrix structure with differentiated, stem or progenitor cells, growing in a bioreactor and transplanting back to the organism could turn out to be a real technological shortcut in the field of tissue engineering. It is not a brand new story on the web,… Continue reading The decellularized matrix hack: skipping many steps in tissue engineering
Halcyon Molecular is a quite ambitious startup, don’t you think? What we do: Halcyon Molecular is developing an ultra-low-cost DNA sequencing technology. Our single molecule approach does not require PCR amplification and will allow for megabase read lengths with simultaneous determination of methylation pattern. We aim to sequence entire human genomes de novo for well… Continue reading Halcyon Molecular: whole genome sequencing well under $1000?
I argued many times here that biology based biotechnology is the next information technology but in order to do so, biotech should harness good IT patterns and mimic its massive computing practices to handle the enormous amount of constantly accumulating data. Often this trend could be summarized in a simple way: keep your eye on… Continue reading Petabyte Age Wiredesque lesson on what science can learn from Google
Even tech people in Silicon Valley need to join their powerful forces and sources when it is about aging related neurodegenerative diseases and help research and the clinic. UCSF Memory and Aging Center channel on YouTube Om Malik: A Personal Note: Pause & Read via John Battelle
It’s my first real encounter with a situation in which the officials of the state of California are clearly against innovation for financial reasons obvious enough (is enough): Wired Science, Alexis Madrigal, upcoming BioBarCamper: Exclusive: DNA Tester Reveals Cease-and-Desist Letter Wired.com has obtained a copy of the cease-and-desist letter sent to Navigenics by the state… Continue reading Innovation stop: “All they’ve done is created an extra billing event for the doctor”
It’s official: The California Department of Public Health wants practicing physicians (many of them prehistorically, sorry, traditionally trained) to be the patres familias in issues between personal genetic test takers and direct-to-consumer personal genetic testing start-ups while declining the test takers’ right to get familiar with their own genetic makeup and risks by their own.… Continue reading Future stop: California health officials against personal genetics risk-takers
The “Understanding Aging: Biomedical and Bioengineering Approaches” conference will be held from June 27-29, 2008 at UCLA organized by Aubrey de Grey, Irina Conboy and Amy Wagers. I like to call it UndertsEnding Aging in myself and I am excited to go to LA and meet new people also people from SENS3. Yesterday I created… Continue reading Understanding Aging Conference on FriendFeed!
The Wall Street Journal Patent Board Biotechnology Scorecard was published this week in which biotech companies & private research firms are grouped by their Patent Board science strength ranking “which is based on the scale, quality, impact, and nearness to core science of a company’s patent-based intellectual property”. What I found interesting at the first… Continue reading Patent Board science strength of biotech firms in WSJ
Just landed in my mailbox, emphasis added by me: Dear Attila, I would like to provide you with a copy of the press release to be distributed via press release distribution sites on Wednesday. We will also put it on our site within a few hours after this email so you can confirm its authenticity.… Continue reading The Biogerontology Research Foundation receives charitable status, UK
“We really think that we can change Health Care…I want to change it in 5 years…it has to change and that’s we all are about” – says Anne Wojcicki, 23andMe co-founder, in the Google Tech Talk on Googling the Googlers’ DNA: A Demonstration of the 23andMe Personal Genome Service. Also a good presentation by Linda… Continue reading The Sergey, Larry, Eric test by Anne & Linda: 23andMe at home
When I wrote about BioBarCamp for the first time, it was just an idea to organize an unconference for biogeeks, people interested in life scientists around SciFoo Camp time. Now thanks to Alex Soojung-Kim Pang, Science X2 project leader, we have a date and a venue: August 6-7, The Institute for the Future, 124 University… Continue reading BioBarCamp: August 6-7, The Institute for the Future, Palo Alto
Monya Baker has an excellent Q&A with the authors of the recent Nature Insight: Regenerative Medicine over at The Niche blog. Ken Chien, the author of Regenerative medicine and human models of human disease – see earlier post – recalls the paradigmatic story of heart transplantation and the 2 main surgeons behind, Norman Shumway and… Continue reading What path would you follow: Shumway or Barnard?
As of this moment the population of The Life Scientists Room on FriendFeed is 73. See the BioGang in motion and get an initial statistics on the distribution of wet lab/dry lab, academic/industrial people there. Here are the first 8 answerers out of the 16 so far.
As far as I understand synthetic morphology = develompental biology +synthetic biology + tissue engineering + anatomy to create new cellular patterns. Jamie A. Davies: Synthetic morphology: prospects for engineered, self-constructing anatomies “This paper outlines prospects for applying the emerging techniques of synthetic biology to the field of anatomy, with the aim of programming cells… Continue reading Synthetic morphology: what kind of animal is that?
Consumer-Enabled Research, the second goal of pioneering personalized genetics company 23andMe, reached its first generation with the launch of 23andWe. From BusinessWire: “23andWe marks a new approach to genetics research. By directly involving 23andMe customers in the company’s research projects, the goal is to conduct large-scale studies powered by a web-based community of diverse individuals… Continue reading 23andWe follows 23andMe: First generation of Consumer-Enabled Research
“I feel like I am talking to an empty room. Why do I feel like I am talking to an empty room?” starts Michael Marron his Google Tech Talk on NIH and the computational infrastructure for biomedical research rather unfortunately. (I remember that room.)
The O’Reilly AlphaTech Ventures Startup Camp is a nice option for the emerging personalized genomics companies or any web-related biotech startups to communicate and cooperate with alpha geeks and early technology adopters. Tim O’Reilly writes: The Thursday and Friday (July 10-11) before this year’s Foo Camp in Sebastopol July 11-13, O’Reilly AlphaTech Ventures will be… Continue reading O’Reilly Startup Camp for geeky biotech startups too!
Nature Biotechnology is the (peer review) journal for me: it’s geeky, fresh and it takes into account more than just one point-of-view, that of the scientist-academist’s: technology & business are hand in hands also. (Recommending Nat Biotech makes a niche sense here while recommending Nature, which is actually the only science journal I’m reading issue… Continue reading Puzzle: Which Wired article is cited in Nature Biotechnology?
With the public launch of the X2 project, Alex Soojung-Kim Pang realized one of his dreams. Alex is the research director of The Institute for the Future (IFTF), an independent nonprofit research group headquartered in Palo Alto, Silicon Valley. He writes: The project is called X2, and its aim is to forecast the future of… Continue reading Embedding the Future: the X2 Project goes public!
It seems that my favorite ever unconference, the SciFoo Camp will be aroundunconferenced by a BioBarCamp this year. The whole idea of the BioBarCamp is based upon the SciFoo Camp, so it is by no means a competitive but a complimentary event. From the BarCamp wiki: “The BioBarCamp is an idea (fed by the tweets… Continue reading BioBarCamp in the Valley before the SciFoo Camp!
Wow, I guess it’s time for me to move into the stock market business! Here’s the story via David Bradley’s tweet: Julie Kent, Search Engine Journal, April 21st, 2008: Google Wants to Index Genetic Information, Invests in Second DNA Start-Up In 2007, Google made headlines when they invested $4.4 million in 23andMe, a genetic screening… Continue reading How to predict the future via Twitter: Google invests in Navigenics
1. A start-up is a company with a limited operating history (Wikipedia). 2. Startup search “tracks the web technology ecosystem commonly referenced as “Web 2.0.” We collect facts and figures about new web products, startup companies, key startup employees, and the funding dollars powering their growth.” 3. 23andMe is a pioneering web-based, personalized genomics startup… Continue reading Dear StartupSearch: Is 23andMe a web-based startup or not?